NYSEMKT: NSRX
Nasus Pharma Ltd Stock

$2.61-0.05 (-1.88%)
Updated Nov 17, 2026
NSRX Price
$2.61
Fair Value Price
N/A
Market Cap
$30.57M
52 Week Low
$1.98
52 Week High
$9.50
P/E
-2.39x
P/B
2.78x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$10.55M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.13
Operating Cash Flow
-$11M
Beta
0.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NSRX's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: General Drug Manufacturer

Industry Rating
A
NSRX
Ranked
Unranked of 16

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$61.35A
$143.37A
$250.79B
View Top General Drug Manufacturer Stocks

Be the first to know about important NSRX news, forecast changes, insider trades & much more!

NSRX News

Overview

Due Diligence Score

–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NSRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NSRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NSRX is good value based on its book value relative to its share price (2.78x), compared to the US Drug Manufacturers - General industry average (8.56x)
P/B vs Industry Valuation
NSRX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NSRX due diligence checks available for Premium users.

Valuation

NSRX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-2.39x
Industry
43.43x
Market
39.5x

NSRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.78x
Industry
8.56x
NSRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NSRX's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
NSRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$12.4M
Liabilities
$1.5M
Debt to equity
0.13
NSRX's short-term assets ($12.31M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NSRX's short-term assets ($12.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NSRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
NSRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NSRX vs General Drug Manufacturer Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NSRX–$30.57M-1.88%-2.39x2.78x
MIRA–$26.89M+1.43%0.62x3.93x
SCLX–$5.45M-48.64%-0.01x-0.02x
MDCXF$2.92M-10.06%-0.02x-0.28x
AMRNC$237.50M-0.35%-11.27x0.53x

Nasus Pharma Stock FAQ

What is Nasus Pharma's quote symbol?

(NYSEMKT: NSRX) Nasus Pharma trades on the NYSEMKT under the ticker symbol NSRX. Nasus Pharma stock quotes can also be displayed as NYSEMKT: NSRX.

If you're new to stock investing, here's how to buy Nasus Pharma stock.

What is the 52 week high and low for Nasus Pharma (NYSEMKT: NSRX)?

(NYSEMKT: NSRX) Nasus Pharma's 52-week high was $9.50, and its 52-week low was $1.98. It is currently -72.53% from its 52-week high and 31.69% from its 52-week low.

How much is Nasus Pharma stock worth today?

(NYSEMKT: NSRX) Nasus Pharma currently has 11,710,808 outstanding shares. With Nasus Pharma stock trading at $2.61 per share, the total value of Nasus Pharma stock (market capitalization) is $30.57M.

Nasus Pharma stock was originally listed at a price of $8.25 in Aug 13, 2025. If you had invested in Nasus Pharma stock at $8.25, your return over the last year would have been -68.36% (not including any dividends or dividend reinvestments).

How much is Nasus Pharma's stock price per share?

(NYSEMKT: NSRX) Nasus Pharma stock price per share is $2.61 today (as of Nov 17, 2026).

What is Nasus Pharma's Market Cap?

(NYSEMKT: NSRX) Nasus Pharma's market cap is $30.57M, as of Nov 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nasus Pharma's market cap is calculated by multiplying NSRX's current stock price of $2.61 by NSRX's total outstanding shares of 11,710,808.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.